Science & Enterprise subscription

Follow us on Twitter

  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 5 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 5 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 8 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Edited Cancer Cell Therapies https://t.co/ck7tBkXfXF #Science #Business
    about 1 day ago

Please share Science & Enterprise

Patent Public Advisory Committee to Meet on 8 July

The Patent Public Advisory Committee to the U.S. Patent and Trademark Office (USPTO) meets on Thursday, 8 July 2010 to review USPTO’s policies and operations related to patents. This session is the group’s fourth of this year.

The patent advisory committee reviews the policies, goals, budget, and user fees set by USPTO, and provides recommendation’s to the agency’s director. The nine-member group chaired by Damon C. Matteo also provides an annual report to the Secretary of Commerce and chairs of the congressional judiciary committees.

The meeting takes place from 8:00 am to 1:30 pm at USPTO’s Madison South Auditorium in Alexandria, Virginia, and is accessible as an online Webcast. The agenda includes a review of USPTO strategy and operations, legislative and judicial updates (including the recent Supreme Court Bilski vs Kappos decision), and reports on process improvement and information technology initiatives.

Updated: 7 July 2010

Comments are closed.